Recent Updates
Recently added Catalysts
STAA Positive Sentiment

STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026

Wednesday, October 21, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: STAAR Surgical Company will release its financial results for Q3 2026 on November 4, 2026. The company, known for its EVO family of Implantable Collamer Lenses, will also host a call and webcast at 5:30 p.m. ET to discuss the results. This event follows the close of the market on the same day.

Market Sentiment Analysis

POSITIVE FACTORS

  • STAAR Surgical is a leader in phakic IOLs.
  • The company is set to release Q3 financial results.
  • An earnings call will provide insights to shareholders.

Full Press Release Details

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results and a letter to shareholders for the third quarter ended October 2, 2026, on Wednesday, November 4, 2026, after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET that same day to discuss its financial results

Frequently Asked Questions

When will STAAR Surgical release Q3 2026 results?

STAAR Surgical will release its Q3 2026 results on November 4, 2026.

What time is the earnings call for Q3 2026?

The earnings call will take place at 5:30 p.m. ET on November 4, 2026.

What is the focus of STAAR Surgical's earnings call?

The call will discuss the company's financial results for Q3 2026.

What product line is STAAR Surgical known for?

STAAR Surgical is known for its EVO family of Implantable Collamer Lenses.

ShareAdd on Google
Tags: STAA STAAR Surgical EVO ICL financial results earnings call Q3 2026
Last updated: Oct 21, 2026

Biotech snapshot

Cash runway
$181M liquidity · $0M/mo burn
Low dilution risk